Oct 3 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- ACCC CONSULTS ON ACL'S PROPOSED DIVESTITURE REMEDY FOR HEALIUS ACQUISITION
- SEEKING VIEWS ON PROPOSED COURT-ENFORCEABLE UNDERTAKING OFFERED BY ACL IN RELATION TO PROPOSED ACQUISITION OF HEALIUS LIMITED
- PROPOSED UNDERTAKING WOULD REQUIRE ACL TO DIVEST 60 ACCS IN PERTH, 25 ACCS ACROSS REGIONAL VICTORIA, AND 14 ACCS IN THE NORTHERN TERRITORY
- DIVESTED ASSETS REPRESENT 16% OF COMBINED APPROVED COLLECTION CENTRES NETWORK OF ACL AND HEALIUS IN WESTERN AUSTRALIA AND 2% IN VICTORIA
(([email protected];))
News: ACL Australia's ACCC Consults On ACL's Proposed Divestiture For Healius Deal
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
0.000(0.00%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.85 | $2.86 | $2.81 | $4.431M | 1.570M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25431 | $2.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.86 | 11164 | 3 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |